Bubs Australia Selects Validcare as CRO for Infant Formula Growth Monitoring Study for U.S. Market Authorization
Validcare announces it contracted with Bubs Australia to run its Growth Monitoring Study (GMS) of 440 healthy term infants. The study’s purpose is to demonstrate acceptable growth and tolerance for three of its products to achieve permanent U.